ResearcherUniversity of MinnesotaNo recent work listed

Satoshi Yamasaki

ORCID-verified (high confidence, 0.95), identity_conf@1As of 7 November 2026

Matched on ORCID iD 0000-0002-9437-3697; OpenAlex author ID A5101786116. Sources: OpenAlex.

Their work

Papers: 1
Trials: 0
Grants: 0
Labs led: 0
Collaborators: 3

Papers, trials and grants by year

2013: 1 paper

Papers 1

Intravenous genetic mesothelin vaccine based on human adenovirus 40 inhibits growth and metastasis of pancreatic cancer. Co-author DOI 10.1002/ijc.27983 ↗

Closest collaborators

The 3 strongest of 3 by collab_strength@1: shared papers, trials and grants, recent and small-team work weighing most.

Selwyn Maurice Vickers · 1 shared paper, 2013 · strength 0.05
- Paper Intravenous genetic mesothelin vaccine based on human adenovirus 40 inhibits growth and metastasis of pancreatic cancer. DOI 10.1002/ijc.27983 ↗
Julia Davydova · 1 shared paper, 2013 · strength 0.05
- Paper Intravenous genetic mesothelin vaccine based on human adenovirus 40 inhibits growth and metastasis of pancreatic cancer. DOI 10.1002/ijc.27983 ↗
Masato Yamamoto · 1 shared paper, 2013 · strength 0.05
- Paper Intravenous genetic mesothelin vaccine based on human adenovirus 40 inhibits growth and metastasis of pancreatic cancer. DOI 10.1002/ijc.27983 ↗

How to reach this person

A chain of introductions through people who have published, run trials or held grants together (warm_path@1: fewest links first, then the strongest). Built from public records only; no contact details are kept.